In vitro studies with Win 42122-2: comparison with gentamicin, netilmicin, and amikacin.
AUTOR(ES)
Sanders, C C
RESUMO
The in vitro activity of Win 42122-2 against gram-negative clinical isolates was compared in serial twofold broth dilution tests with gentamicin, netilmicin, and amikacin. Against 173 gentamicin-susceptible Enterobacteriaceae, the activity of Win 42122-2 was generally twofold less than those of gentamicin or netilmicin and similar to that of amikacin. Against 60 gentamicin-susceptible nonfermentative gram-negative bacilli, including P. aeruginosa, the activity of Win 42122-2 was four- to eightfold less than that of gentamicin or netilmicin and two- to fourfold less than that of amikacin. Minimal bacterial concentrations for Win 42122-2 were usually similar to minimal inhibitory concentrations. Win 42122-2 was not highly active against gentamicin-resistant bacteria. Win 42122-2 was as active as gentamicin against Mycobacterium tuberculosis but was less active than gentamicin or amikacin against atypical mycobacteria. Win 42122-2 interacted synergistically with penicillin G against enterococci, including strains highly resistant to streptomycin.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=181672Documentos Relacionados
- In Vitro Activity of Netilmicin, Gentamicin, and Amikacin
- In Vitro Studies with Netilmicin Compared with Amikacin, Gentamicin, and Tobramycin
- Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin.
- Renal disposition of gentamicin, dibekacin, tobramycin, netilmicin, and amikacin in humans.
- Comparative uptake of gentamicin, netilmicin, and amikacin in the guinea pig cochlea and vestibule.
